During the Congressional recess in August, GLI prepared for a busy fall. Congress returns in September to advance appropriations bills and debate key legislative priorities. The Administration will...
At GLI, we aim to keep you updated on the latest innovations and advancements in liver cancer. As we begin to approach Liver Cancer Awareness Month, take a look at our liver cancer resources that...
Concerted efforts are driving positive change in the pediatric and rare liver disease community! Read on for details: Insight on Unmet Needs in Primary Biliary Cholangitis In this Peer Exchange...
GLI Supports NIH Naming Dr. Marrazzo as New Director of the National Institute of Allergy and Infectious Diseases Global Liver Institute supports the selection of Jeanne M. Marrazzo, M.D., as...
Read along for some updates about cutting-edge technology in rare liver disease that should improve prompt diagnosis, ongoing feedback, and effective interventions. Vote for GLI for a Healio...
In July, GLI used its voice to challenge policymakers to take steps to advance high quality, equitable care for everyone. We met with key Members of Congress to push for action to reform the organ...
Welcome back to Liver Cancers News – where we keep you up-to-date on what’s happening in the liver cancer world. Vote for GLI for a Healio Disruptive Innovators Award Great news! Healio named GLI...
GLI and Others Nominate Julius M. Wilder MD, PhD to National Diabetes and Digestive and Kidney Diseases Advisory Council (NDDKAC) Global Liver Institute is pleased to nominate Julius M....
GLI Urges Passage of the Treat and Reduce Obesity Act (TROA) Global Liver Institute recognizes the relationship between nonalcoholic fatty liver disease (NAFLD), its advanced form,...
International NASH Day was a success! The 6th International NASH Day was a resounding global success, with over 100 partners from 55 countries participating. Our hashtag #NASHDay reached over 10...
Recent News
Congress returned in September to advance appropriations bills and debate key legislative priorities, while the administration worked on policies impacting liver health by addressing disability protections in organ transplantation and with regard to the Cancer...
Building on Fatty Liver Awareness and Treatments As prospects for new fatty liver and NASH treatments appear on the horizon, GLI continues to push for better awareness, screening, and treatment options. With fatty liver disease being diagnosed in a growing pediatric...
This month, significant strides have been made in addressing rare liver disease care. Updates to patient registries, novel therapeutic options, and strategies for expediting prior authorizations in rare diseases are highlighted below. PFIC Patient...
#OctoberIs4Livers Join us throughout the month for our #OctoberIs4Livers campaign, the first and only global program dedicated to public awareness, policy, and clinical practice needs to prevent and manage liver cancer while educating and empowering those living with...
Global Communities Rally around Third Deadliest Cancer – Liver Cancer Global Liver Institute Leads International Program to Build Hope and Raise Awareness during October, Liver Cancer Awareness Month (Washington, D.C., October 1, 2023) – Today marks the start of...
